The cre-inducer doxycycline lowers cytokine and chemokine transcript levels in the gut of mice

Axel Kornerup Hansen*, Sara Astrup Malm, Stine B. Metzdorff

*Corresponding author for this work
    1 Citation (Scopus)

    Abstract

    The antibiotic doxycycline is used as an inducer of recombinase (cre)-based conditional gene knockout in mice, which is a common tool to show the effect of disrupted gene functions only in one period of a research animal’s life. However, other types of such antibiotics have been shown to have a strong impact on the immune system. Here we show that in C57BL/6 mice, the most commonly applied strain for genetic modification, doxycycline treatment lowered transcription of the genes Il1b, Il10, Il18, Tnf, Cxcl1, and Cxcl2 in the ileum, and of the gene Il18 in colon. Cytokines and chemokines encoded by these genes are important in the disease expression in a range of mouse models. Although protein abundances only rarely correlate 100% to transcript levels, and the net result, therefore, may be less dramatic, it seems reasonable to be aware that a broad spectrum antibiotic, such as doxycycline, may impact the transgenic animal in ways unrelated to the activation of the gene deletion.

    Original languageEnglish
    JournalJournal of Applied Genetics
    Volume58
    Issue number4
    Pages (from-to)535-538
    Number of pages4
    ISSN1234-1983
    DOIs
    Publication statusPublished - Nov 2017

    Keywords

    • Chemokines
    • Cytokines
    • Doxycycline
    • Gene knockout techniques
    • Mice

    Fingerprint

    Dive into the research topics of 'The cre-inducer doxycycline lowers cytokine and chemokine transcript levels in the gut of mice'. Together they form a unique fingerprint.

    Cite this